Search Within

Nadeem Riaz

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (5)
  3. Research Letter (2)
Groups
  1. Department of Medicine (18)
  2. Genitourinary Oncology Service (18)
  3. Radiation Oncology, Department of (18)
  4. Solid Tumor Oncology Division (18)
  5. GSK Faculty (15)
  6. Department of Pathology and Laboratory Medicine (14)

More Groups

People
  1. Timothy Chan (10)
  2. David Solit (8)
  3. Nancy Lee (8)
  4. Luc Morris (7)
  5. Abraham Hakimi (6)
  6. Ahmet Zehir (5)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (3)
  5. 2020 (1)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Clinical Cancer Research (3)
  3. Nature Genetics (2)
  4. Cancer Discovery (1)
  5. European Journal of Cancer (1)
  6. International Journal of Radiation Oncology, Biology, Physics (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. American Association for Cancer Research (4)
  3. Nature Publishing Group (3)
  4. Elsevier Inc. (2)
  5. American Association for the Advancement of Science (1)
  6. American Medical Association (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
    Journal Article

    Liu, S. Y.; Erazo, T.; Jee, J.; Arfe, A.; Gupta, A.; Pike, L. R. G.; Santini, F. C.; Daly, B.; Schoenfeld, A.; Eichholz, J.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
    Journal Article

    Valero, C.; Golkaram, M.; Vos, J. L.; Xu, B.; Fitzgerald, C.; Lee, M.; Kaplan, S.; Han, C. Y.; Pei, X.; Sarkar, R.; more...
    Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • Prognostic and predictive implications of plasma ctDNA in guiding first-line targeted therapy for metastatic HER2 -mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Liu, S. Y.; Jee, J.; Santini, F. C.; Schoenfeld, A. J.; Eichholz, J.; Johnson, K.; Martinez, A.; Guo, J.; Riaz, N.; Lee, N. Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
    Journal Article

    Chowell, D.; Yoo, S. K.; Valero, C.; Pastore, A.; Krishna, C.; Lee, M.; Hoen, D.; Shi, H.; Kelly, D. W.; Patel, N.; more...
    Nature Biotechnology (2022)

    Fulltext@MSK | Save
  • Pathogenic ATM mutations in cancer and a genetic basis for radiotherapeutic efficacy
    Journal Article

    Pitter, K. L.; Casey, D. L.; Lu, Y. C.; Hannum, M.; Zhang, Z.; Song, X.; Pecorari, I.; McMillan, B.; Ma, J.; Samstein, R. M.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • The genetic evolution of treatment-resistant cutaneous, acral, and uveal melanomas
    Journal Article

    Makohon-Moore, A. P.; Lipson, E. J.; Hooper, J. E.; Zucker, A.; Hong, J.; Bielski, C. M.; Hayashi, A.; Tokheim, C.; Baez, P.; Kappagantula, R.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • The association between tumor mutational burden and prognosis is dependent on treatment context
    Research Letter

    Valero, C.; Lee, M.; Hoen, D.; Wang, J.; Nadeem, Z.; Patel, N.; Postow, M. A.; Shoushtari, A. N.; Plitas, G.; Balachandran, V. P.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • A phase 1b study of cetuximab and BYL719 (alpelisib) concurrent with intensity modulated radiation therapy in stage III-IVB head and neck squamous cell carcinoma
    Journal Article

    Dunn, L. A.; Riaz, N.; Fury, M. G.; McBride, S. M.; Michel, L.; Lee, N. Y.; Sherman, E. J.; Baxi, S. S.; Haque, S. S.; Katabi, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Alterations in DNA damage repair (DDR) genes and outcomes to systemic therapy in 225 immune-oncology (10) versus tyrosine kinase inhibitor (TKI) treated metastatic clear cell renal cell carcinoma (mccRCC) patients (pts)
    Meeting Abstract

    Ged, Y.; Chaim, J.; Knezevic, A.; Carlo, M. I.; Foster, A.; Feldman, D. R.; Teo, M. Y.; Riaz, N.; Lee, C. H.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Transcriptomic profiling of the tumor microenvironment reveals distinct subgroups of clear cell renal cell cancer: Data from a randomized phase III trial
    Journal Article

    Hakimi, A. A.; Voss, M. H.; Kuo, F.; Sanchez, A.; Liu, M.; Nixon, B. G.; Vuong, L.; Ostrovnaya, I.; Chen, Y. B.; Reuter, V.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save